China’s state-run Global Times on Thursday reported that BioNTech, the German company that partnered with American company Pfizer to produce its coronavirus vaccine, is “considering to evaluate” mixing its mRNA product with the vaccine manufactured by China’s Fosun Pharma.
Europe can achieve herd immunity against the coronavirus within the next four months, the head of pharmaceutical company BioNTech said.
The Chinese pharmaceutical company Sinopharm announced on Wednesday that Phase III clinical trials found their Chinese coronavirus vaccine candidate to be 72.51 percent effective in preventing infections.
A U.S. Food and Drug Administration (FDA) advisory panel on Thursday voted to recommend the emergency use approval of the Moderna vaccine.
Germany’s fourth-term Chancellor, Angela Merkel, banged her podium in the German parliament and spoke of families’ “last Christmas with the grandparents” as she moves to shut down the country. 66-year-old Merkel, widely regarded as the most powerful and influential leader
Shanghai Fosun Pharmaceutical Group, a Chinese pharmaceutical group, announced Wednesday it had inked a deal with German company BioNTech to purchase 100 million doses of the Chinese coronavirus vaccine it had developed with American company Pfizer — the first vaccine approved for use in the United States.
A nurse in New York received one of the first doses of the Pfizer vaccine recently approved by U.S. regulators.
Workers at Pfizer’s Michigan headquarters paused for a moment and erupted into a round of applause early Sunday morning as the first shipments of the coronavirus vaccine were being moved to a loading dock.
The Food and Drug Administration (FDA) on Friday night approved the first coronavirus vaccine for emergency use in the United States, several media outlets reported, clearing the way for U.S. officials to begin vaccinating millions of Americans as early as next week.
The European Medicines Agency’s documents on the Pfizer/BioNTech vaccine have been hacked by cyber-attackers.
